Search Results - Reiffel, James

Refine Results
  1. 1
    Editorial: Advances in The Therapy of Atrial Fibrillation: Incrementally Progressive But Not Without Missteps

    Editorial: Advances in The Therapy of Atrial Fibrillation: Incrementally Progressive But Not Without Missteps by Reiffel, James A

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Are we at the Goal Line with the Novel Oral Anticoagulants and Have We Reached the End of the Line for Dronedarone and Vernakalant – or is There More to Come?

    Are we at the Goal Line with the Novel Oral Anticoagulants and Have We Reached the End of the Line for Dronedarone and Vernakalant – or is There More to Come? by Reiffel, James A

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Does the FDA Owe Us an Explanation?

    Does the FDA Owe Us an Explanation? by Reiffel, James A

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    The Power of One: a Highly Detailed, Log-Based, Case Example that Clearly Demonstrates the Effective Use of Ranolazine for the Control of Progressive Atrial Fibrillationn

    The Power of One: a Highly Detailed, Log-Based, Case Example that Clearly Demonstrates the Effective Use of Ranolazine for the Control of Progressive Atrial Fibrillationn by Reiffel, James A

    Published 2010
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    The New Novel Oral Anticoagulants (NOACs) In Patients With Atrial Fibrillation: Dogma, Dilemmas, And Decisions On Dosing

    The New Novel Oral Anticoagulants (NOACs) In Patients With Atrial Fibrillation: Dogma, Dilemmas, And Decisions On Dosing by Reiffel, James A

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    GIANT Flutter Waves in ECG Lead V1: a Marker of Pulmonary Hypertension

    GIANT Flutter Waves in ECG Lead V1: a Marker of Pulmonary Hypertension by Reiffel, James A

    Published 2008
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Dronedarone: Where Does it Fit in the AF Therapeutic Armamentarium?

    Dronedarone: Where Does it Fit in the AF Therapeutic Armamentarium? by Reiffel, James A

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Dronedarone For Atrial Fibrillation: Unbridled Enthusiasm Or Just Another Small Step Forward?

    Dronedarone For Atrial Fibrillation: Unbridled Enthusiasm Or Just Another Small Step Forward? by Reiffel, James A

    Published 2009
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Rate Versus Rhythm Control Pharmacotherapy For Atrial Fibrillation: Where are We in 2008?

    Rate Versus Rhythm Control Pharmacotherapy For Atrial Fibrillation: Where are We in 2008? by Reiffel, James A

    Published 2008
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    The Anticoagulated Atrial Fibrillation Patient Who Requires “Curative” Therapy for Prostate Carcinoma: a Bleeding Conundrum

    The Anticoagulated Atrial Fibrillation Patient Who Requires “Curative” Therapy for Prostate Carcinoma: a Bleeding Conundrum by Reiffel, James A

    Published 2008
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Time to Revisit the Time in the Therapeutic Range

    Time to Revisit the Time in the Therapeutic Range by A. Reiffel, James

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Optimum Risk Assessment for Stroke in Atrial Fibrillation: Should We Hold the Status Quo or Consider Magnitude Synergism and Left Atrial Appendage Anatomy?

    Optimum Risk Assessment for Stroke in Atrial Fibrillation: Should We Hold the Status Quo or Consider Magnitude Synergism and Left Atrial Appendage Anatomy? by Reiffel, James A

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Complexities in the Atrial Fibrillation-Stroke Relationship: Improving Comprehension of Temporal Discordance, Magnitude Synergism, and Subclinical Atrial Fibrillation -- Three Sources of Consternation for Physicians Who Care for Patients with Atrial Fibrillation

    Complexities in the Atrial Fibrillation-Stroke Relationship: Improving Comprehension of Temporal Discordance, Magnitude Synergism, and Subclinical Atrial Fibrillation -- Three Sour... by Reiffel, James A.

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    Propensity-Score Matching: Optimal, Adequate, or Incomplete?

    Propensity-Score Matching: Optimal, Adequate, or Incomplete? by Reiffel, James A.

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    Practical algorithms for pharmacologic management of the post myocardial infarction patient

    Practical algorithms for pharmacologic management of the post myocardial infarction patient by Reiffel, James A.

    Published 2009
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    Intra-Atrial Block: Definition and Relationship to Atrial Fibrillation and Other Adverse Outcomes

    Intra-Atrial Block: Definition and Relationship to Atrial Fibrillation and Other Adverse Outcomes by A. Reiffel, James

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    Reduced-dose Antiarrhythmic Drugs: Valuable or Valueless?

    Reduced-dose Antiarrhythmic Drugs: Valuable or Valueless? by Reiffel, James A.

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    TTR: Time in Therapeutic Range or “The Troublesome Report”?

    TTR: Time in Therapeutic Range or “The Troublesome Report”? by Reiffel, James A.

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    When Silence Isn’t Golden: The Case of “Silent” Atrial Fibrillation

    When Silence Isn’t Golden: The Case of “Silent” Atrial Fibrillation by Reiffel, James A.

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    Oral Anticoagulation and Antiarrhythmic Drug Therapy for Atrial Fibrillation

    Oral Anticoagulation and Antiarrhythmic Drug Therapy for Atrial Fibrillation by Reiffel, James A.

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: